Primarily based in Brussels, the team at Deloitte Legal exhibits ‘clear, in-depth’ expertise across a broad range of areas, with particular emphasis on medtech regulatory matters. Practice head Christoph Michiels has ample expertise in venture capital and private equity transactions, regularly assisting investor syndicates and management teams with early stage spin off projects. Jean-Christophe Top acts for numerous pharma, digital health, and medtech clients in matters concerning ethics compliance and the commercialisation of novel therapies, while Matthias Vierstraete maintains an IP and IT focused practice in Ghent.
Testimonials
Collated independently by Legal 500 research team.
‘The team is very diverse, so we have easy access to a lot of different profiles when addressing different challenges.’
‘Jean-Christophe Top is our principal contact, he reacts rapidly and very efficiently to our different requests. Matthias Vierstraete is experienced and provides valuable advice.’
‘Up-to-date knowledge of applicable legislation, fluid communication, and timely service.’
‘Clear, in-depth individual expertise in each field.’
‘I am satisfied with the services of the firm. Their professionalism and expertise are good and they deliver their services with thoroughness and sufficient quality. What really sets them apart is their expertise in the complex world of CE marking for medical applications; they have a thorough understanding of the regulations and their guidance was helpful when navigating the complicated requirements.’
‘The team goes to great lengths, digging into regulations as well as recent and longer-standing caselaw to prepare a case to perfection.’
‘The staff assumes their own knowledge, but tests it against our knowledge and experience to arrive at a match. There is true cooperation with mutual respect.’
Key clients
- Nipro Medical Europe
- Nipro Digital Technologies Europe
- The Akkermansia Company
- QLEVR
- S-Biomedic
- Indigo Diabetes
- VIPUN Medical
- D-Tek
- eTheRNA Immunotherapies
- UC-Leuven Limburg (UCLL)
- European Cystic Fybrosis Society
- Belgian State, FPS Public Health
- IBSA
- Agomab Therapeutics
- Amber Technologies
- Aphea
- Apitope International
- Augustine Therapeutics
- Bioqube Ventures
- Complix
- Deuteroncology
- Dualyx
- FOx Biosystems
- Inbiose
- Minoryx Therapeutics BE
- MRM Technologies
- MRM Health
- Prodigest
- Protealis
- Rewind Therapeutics
- S-biomedic
- Vipun Medical
Work highlights
- Advising Nipro Medical Europe on regulatory life sciences, and IP and IT matters. The firm is advising on the client's MDR and Brexit transition, and continues to assist the company with agreements, complaints/notifications from notified bodies and authorities alike, medical device borderline cases, transition towards an eQMS, ethical and sunshine act considerations.
- Assisted FPS Public Health with setting up the Belgian Health Data Agency (HDA).
- Assisted Aphea.Bio with its Series C investment round of approx. €70m (including assistance with negotiations and the drafting of the shareholders and subscription agreement, stock option plan) and closing of the first tranche capital increase of approximately €25m.
Practice head
The lawyer(s) leading their teams.
Christoph Michiels